The incidence of @entity14 increased in France until the 2000s' then decreased. Time trends in incidence for this @entity5 varied according to its sublocation along the gut. Incidence increased for right and left @entity694 , whereas it remained stable for sigmoid @entity5 in males and decreased in females. Incidence decreased over time for @entity5 . The proportion of @entity14 in the overall French @entity5 prevalence is 12%. In 2008, 121,000 @entity1 had a @entity14 diagnosed in the 5 previous years. The cumulative risk of @entity14 increased from 3.9% for males born around 1900 to 4.9% for those born around 1930 and then slightly decreased, being 4.5% among those born around 1950. It remained at the same level for females and was 2.9% for those born around 1950. The prognosis of @entity14 improved over time. @entity68686 -year survival increased in males from 53% for @entity5 diagnosed between 1989 and 1991 to 58% for those diagnosed between 2001 and 2004. The highest improvement of 10 year survival rates concerned left colon and rectosigmoid junction (+19% in a decade). The progressive set up of national colorectal screening since the early 2000's and the introduction of recent immunological tests in 2015 should decrease the mortality for this @entity5 and, at term, should decrease its incidence too.

[Epidemiology of XXXX ].

@entity1 :: ('9606', 'Species') :: ['patients'] @entity5 :: ('MESH:D009369', 'Disease') :: ['cancers', 'rectal cancers', 'cancer'] @entity14 :: ('MESH:D015179', 'Disease') :: ['colorectal cancer'] @entity68686 :: ('10867', 'Gene') :: ['Net 5'] @entity694 :: ('MESH:D003110', 'Disease') :: ['colon cancers']
@entity14 :: (MESH:D015179,Disease) :: ['colorectal cancer']
